Alpha‐defensins: risk factor for thrombosis in COVID‐19 infection

The inflammatory response to SARS/CoV‐2 (COVID‐19) infection may contribute to the risk of thromboembolic complications. α‐Defensins, antimicrobial peptides released from activated neutrophils, are anti‐fibrinolytic and prothrombotic in vitro and in mouse models. In this prospective study of 176 pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Abdeen, Suhair, Bdeir, Khalil, Abu‐Fanne, Rami, Maraga, Emad, Higazi, Mohamed, Khurram, Nigar, Feldman, Michael, Deshpande, Charuhas, Litzky, Leslie A., Heyman, Samuel N., Montone, Kathleen T., Cines, Douglas B., Higazi, Abd Al‐Roof
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Covid‐19
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239944/
https://ncbi.nlm.nih.gov/pubmed/34053084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados